Publications
2021
Reply to: Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease"."
Simbrunner B,
Costa D,
Reiberger T.
J Hepatol. 2021 Apr 20:S0168-8278(21)00233-6. doi: 10.1016/j.jhep.2021.03.027. Online ahead of print.
2021
Reply to: Prognostic role of systemic inflammatory biomarkers in advanced chronic liver disease"."
Costa D,
Simbrunner B,
Reiberger T.
J Hepatol. 2021 Apr;74(4):1000-1001. doi: 10.1016/j.jhep.2021.01.026. Epub 2021 Jan 23.
2021
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D,
Simbrunner B,
Jachs M,
Hartl L,
Bauer D,
Paternostro R,
Schwabl P,
Scheiner B,
Stättermayer AF,
Pinter M,
Trauner M,
Mandorfer M,
Reiberger T.
J Hepatol. 2021 Apr;74(4):819-828. doi: 10.1016/j.jhep.2020.10.004. Epub 2020 Oct 16.
2021
The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model.
Schwabl P,
Hambruch E,
Budas GR,
Supper P,
Burnet M,
Liles JT,
Birkel M,
Brusilovskaya K,
Königshofer P,
Peck-Radosavljevic M,
Watkins WJ,
Trauner M,
Breckenridge DG,
Kremoser C,
Reiberger T.
Biomedicines. 2021 Jan 9;9(1):60. doi: 10.3390/biomedicines9010060.
2020
Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.
Simbrunner B,
Marculescu R,
Scheiner B,
Schwabl P,
Bucsics T,
Stadlmann A,
Bauer DJM,
Paternostro R,
Eigenbauer E,
Pinter M,
Stättermayer AF,
Trauner M,
Mandorfer M,
Reiberger T.
Liver Int. 2020 Jul;40(7):1713-1724. doi: 10.1111/liv.14498. Epub 2020 May 18.
2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated rats.
Brusilovskaya K,
Königshofer P,
Lampach D,
Szodl A,
Supper P,
Bauer D,
Beer A,
Stift J,
Timelthaler G,
Oberhuber G,
Podesser BK,
Seif M,
Zinober K,
Rohr-Udilova N,
Trauner M,
Reiberger T,
Schwabl P.
United European Gastroenterol J. 2020 Dec;8(10):1174-1185. doi: 10.1177/2050640620944140. Epub 2020 Sep 2.
2020
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.
Costa D,
Simbrunner B,
Jachs M,
Hartl L,
Bauer D,
Paternostro R,
Schwabl P,
Scheiner B,
Stättermayer AF,
Pinter M,
Trauner M,
Mandorfer M,
Reiberger T.
J Hepatol. 2021 Apr;74(4):819-828. doi: 10.1016/j.jhep.2020.10.004. Epub 2020 Oct 16.
2020
PIDDosome-induced p53-dependent ploidy restriction facilitates hepatocarcinogenesis.
Sladky VC,
Knapp K,
Szabo TG,
Braun VZ,
Bongiovanni L,
van den Bos H,
Spierings DC,
Westendorp B,
Curinha A,
Stojakovic T,
Scharnagl H,
Timelthaler G,
Tsuchia K,
Pinter M,
Semmler G,
Foijer F,
de Bruin A,
Reiberger T,
Rohr-Udilova N,
Villunger A.
EMBO Rep. 2020 Dec 3;21(12):e50893. doi: 10.15252/embr.202050893. Epub 2020 Nov 23.
2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosis.
Simbrunner B,
Semmler G,
Stadlmann A,
Scheiner B,
Schwabl P,
Paternostro R,
Bucsics T,
Bauer D,
Eigenbauer E,
Pinter M,
Stättermayer AF,
Quehenberger P,
Marculescu R,
Trauner M,
Mandorfer M,
Reiberger T.
Hepatol Int. 2020 Dec;14(6):1093-1103. doi: 10.1007/s12072-020-10112-3. Epub 2020 Dec 8.
2020
Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension.
Wöran K,
Semmler G,
Jachs M,
Simbrunner B,
Maria Bauer DJ,
Binter T,
Pomej K,
Stättermayer AF,
Schwabl P,
Bucsics T,
Paternostro R,
Lampichler K,
Pinter M,
Trauner M,
Mandorfer M,
Stift J,
Reiberger T,
Scheiner B.
Clin Gastroenterol Hepatol. 2020 Dec 3:S1542-3565(20)31629-3. doi: 10.1016/j.cgh.2020.11.039. Epub ahead of print.
